Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Bracoud

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Brain Communications|December 23, 2021
Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementiaVesna Vuksanović, Roger T Staff, Suzannah Morson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2022
Comparing ARIA-E severity scales and effects of treatment management thresholdsGregory Klein, Marzia A Scelsi, Jerome Barakos, et al.
Clinical Neuroradiology|April 21, 2026
Automated Deep Learning-Based Demyelination Load Segmentation in Metachromatic LeukodystrophyPascal Martin, Joël Schaerer, Thomas Cajgfinger, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's diseaseAdam J Schwarz, Karen L Sundell, Arnaud Charil, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumChris Conklin, Stefan Radonjic, David Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2019
Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?Kevin McRae-McKee, Chinedu T Udeh-Momoh, Geraint Price, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 20, 2025
Prevalence and risk factors of cerebral microhemorrhages and superficial siderosis in cognitively unimpaired older adults: analysis from the CHARIOT-PRO SubStudySujin Kang, Dimitra Kafetsouli, Jamie Ford, et al.
Journal of Alzheimer'S Disease : JAD|October 29, 2019
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's DiseaseBjoern O Schelter, Helen Shiells, Thomas C Baddeley, et al.
Lancet (London, England)|November 20, 2016
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trialSerge Gauthier, Howard H Feldman, Lon S Schneider, et al.
Journal of Alzheimer'S Disease : JAD|April 14, 2020
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal DementiaHelen Shiells, Bjoern O Schelter, Peter Bentham, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Brain Communications|December 23, 2021
Degeneration of basal and limbic networks is a core feature of behavioural variant frontotemporal dementiaVesna Vuksanović, Roger T Staff, Suzannah Morson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2022
Comparing ARIA-E severity scales and effects of treatment management thresholdsGregory Klein, Marzia A Scelsi, Jerome Barakos, et al.
Clinical Neuroradiology|April 21, 2026
Automated Deep Learning-Based Demyelination Load Segmentation in Metachromatic LeukodystrophyPascal Martin, Joël Schaerer, Thomas Cajgfinger, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2019
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's diseaseAdam J Schwarz, Karen L Sundell, Arnaud Charil, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumChris Conklin, Stefan Radonjic, David Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2019
Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?Kevin McRae-McKee, Chinedu T Udeh-Momoh, Geraint Price, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 20, 2025
Prevalence and risk factors of cerebral microhemorrhages and superficial siderosis in cognitively unimpaired older adults: analysis from the CHARIOT-PRO SubStudySujin Kang, Dimitra Kafetsouli, Jamie Ford, et al.
Journal of Alzheimer'S Disease : JAD|October 29, 2019
Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's DiseaseBjoern O Schelter, Helen Shiells, Thomas C Baddeley, et al.
Lancet (London, England)|November 20, 2016
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trialSerge Gauthier, Howard H Feldman, Lon S Schneider, et al.
Journal of Alzheimer'S Disease : JAD|April 14, 2020
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal DementiaHelen Shiells, Bjoern O Schelter, Peter Bentham, et al.
Pageof 3